134 related articles for article (PubMed ID: 11164176)
1. Alpha-blockade downregulates myosin heavy chain gene expression in human benign prostatic hyperplasia.
Lin VK; Benaim EA; McConnell JD
Urology; 2001 Jan; 57(1):170-5. PubMed ID: 11164176
[TBL] [Abstract][Full Text] [Related]
2. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist.
Boesch ST; Corvin S; Zhang J; Rogatsch H; Bartsch G; Klocker H
Prostate; 1999 Jun; 39(4):226-33. PubMed ID: 10344211
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term castration on the smooth muscle cell phenotype of the rat ventral prostate.
Antonioli E; Cardoso AB; Carvalho HF
J Androl; 2007; 28(5):777-83. PubMed ID: 17522419
[TBL] [Abstract][Full Text] [Related]
5. Testosterone regulates myosin II isoforms expression and functional activity in the rat prostate.
Chen P; Xiao H; Huang W; Xu DQ; Guo YM; Wang X; Wang XH; DiSanto ME; Zhang XH
Prostate; 2018 Dec; 78(16):1283-1298. PubMed ID: 30073674
[TBL] [Abstract][Full Text] [Related]
6. Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
Lin VK; Wang SY; Boetticher NC; Vazquez DV; Saboorian H; McConnell JD; Roehrborn CG
Prostate; 2005 May; 63(3):299-308. PubMed ID: 15611997
[TBL] [Abstract][Full Text] [Related]
7. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
8. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 regulates cell growth and causes downregulation of SMemb/non-muscle myosin heavy chain B mRNA in human prostate stromal cells.
Obara K; Bilim V; Suzuki K; Kobayashi K; Hara N; Kasahara T; Nishiyama T; Takahashi K
Scand J Urol Nephrol; 2005; 39(5):366-71. PubMed ID: 16257837
[TBL] [Abstract][Full Text] [Related]
10. Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate.
He W; Wang X; Zhan D; Li M; Wang Q; Liu J; Liu D; Fu X; Qian Q; Li Y; Chen P; Zeng G; Wang X; DiSanto ME; Zhang X
Clin Sci (Lond); 2021 Jan; 135(1):167-183. PubMed ID: 33393635
[TBL] [Abstract][Full Text] [Related]
11. The effect of combined androgen ablation on the expression of alpha1A-adrenergic receptor in the human prostate.
Benaim EA; Karam JA; Soboorian MH; Roehrborn CG; McConnell JD; Lin V
Prostate; 2004 Sep; 60(4):310-6. PubMed ID: 15264242
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
[TBL] [Abstract][Full Text] [Related]
13. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
[TBL] [Abstract][Full Text] [Related]
14. The expression and functional activities of smooth muscle myosin and non-muscle myosin isoforms in rat prostate.
Chen P; Yin J; Guo YM; Xiao H; Wang XH; DiSanto ME; Zhang XH
J Cell Mol Med; 2018 Jan; 22(1):576-588. PubMed ID: 28990332
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.
Kojima Y; Sasaki S; Kubota Y; Hayase M; Hayashi Y; Shinoura H; Tsujimoto G; Kohri K
J Urol; 2008 Mar; 179(3):1040-6. PubMed ID: 18206918
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products interfere with gastric smooth muscle contractile marker expression via the AGE/RAGE/NF-κB pathway.
Yu T; Zheng Y; Wang Y; Xiong W; Lin L
Exp Mol Pathol; 2017 Feb; 102(1):7-14. PubMed ID: 27939576
[TBL] [Abstract][Full Text] [Related]
18. Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content.
Shibata Y; Arai S; Miyazawa Y; Shuto T; Nomura M; Sekine Y; Koike H; Matsui H; Ito K; Suzuki K
Prostate; 2017 May; 77(6):672-680. PubMed ID: 28145028
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
20. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
